Table 1.
Patient characteristics (n = 54)
| Age (year) | Median (range) |
| At primary diagnosis | 54 (26–76) |
| At second-line chemotherapy | 55 (28–77) |
| At third-line chemotherapy | 55 (31–78) |
| Performance status | |
| 0 | 6 |
| 1 | 22 |
| 2 | 24 |
| 3 | 2 |
| Stage | |
| I | 4 |
| II | 5 |
| III | 30 |
| IV | 15 |
| Organ | |
| Ovarian carcinoma | 46 |
| Primary peritoneal carcinoma | 7 |
| Fallopian tube carcinoma | 1 |
| Pathology | |
| Serous adenocarcinoma | 40 |
| Endometrioid adenocarcinoma | 2 |
| Mucinous adenocarcinoma | 1 |
| Clear cell carcinoma | 5 |
| Undifferentiated carcinoma | 6 |
| No. of target lesions | |
| 1 | 38 |
| 2 | 10 |
| 3 | 6 |
| Drug free-interval (month) | |
| Primary | 8.2 (0.9–39.3) |
| Secondary | 8.3 (0.1–21.5) |
| 3rd-line regimens | |
| Platinum/taxane-containing regimens | 36 |
| Other regimens | 18 |